According to foreign media TechCrunch, one of the ways currently being sought to develop effective treatments for COVID-19 is to use convalescent plasma. Basically, this means using plasma from COVID-19 patients who have fully recovered, hoping to transfer the antibodies they produced during the fight against the virus to others.
US Food and Drug Administration (FDA) creates dedicated website to seek recovery plasma donationsThe US Food and Drug Administration (FDA) has created a dedicated new website that seeks recovery plasma donations from COVID-19 rehabilitation patients and explains their potential uses.
The use of plasma during recovery is hardly a new concept. In fact, it has been used since the late 1890s and was used during the Spanish influenza pandemic in 1918, although "the results were mixed."
Modern methods can help improve the efficacy and potential of recovered plasma as a therapeutic method. There are currently some drugs under development that use plasma (animals and humans) as the basic active ingredients of their methods.
The new FDA website around COVID-19 plasma donation defines what it is and why it is a possible treatment. It also outlines the conditions that an individual needs to meet in order to be eligible for donation (when there are no symptoms for at least 28 days before donation, or at least 14 days when combined with laboratory-confirmed COVID-19 viral plasma). Also, guides people through the American Red Cross Or donate at a nearby local blood center.
Since plasma therapy in the recovery phase is still used as a potential therapy, why do we need so many COVID-19 patient plasma?This is mainly because there is a lot of work underway to determine whether it can really help fight the virus, including clinical trials of several different treatments, and the one-time approved through the FDA’s emergency investigational new drug (eIND) program Single disease treatment authorization.
As with every potential treatment and vaccine being developed at this stage, convalescence plasma therapies have not yet been proven, and efforts currently underway to study its effectiveness are unlikely to be in one way or another in the short term To prove its effectiveness. Nonetheless, the demand for plasma supply is still growing to help drive this work, so the FDA decided to encourage more donations through specialized information resources like this.